BALTIMORE (Stockpickr) --�Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating investment ideas. Instead, let the crowd do it for you.
>>5 Rocket Stocks to Buy for Earnings Season
From hedge funds to individual investors, scores of market participants are turning to social media to figure out which stocks are worth watching. It's a concept that's known as "crowdsourcing," and it uses the masses to identify emerging trends in the market.
Crowdsourcing has long been a popular tool for the advertising industry, but it also makes a lot of sense as an investment tool. After all, the market is completely driven by the supply and demand, so it can be valuable to see what names are trending among the crowd.
While some fund managers are already trying to leverage social media resources such as Twitter to find algorithmic trading opportunities, for most investors, crowdsourcing works best as a starting point for investors who want a starting point in their analysis. Today, we'll leverage the power of the crowd to take a look at some of the most active stocks on the market today.
5 Best Heal Care Stocks To Own For 2015: ValueClick Inc.(VCLK)
ValueClick, Inc. provides various products and services that enable marketers to advertise and sell their products through online marketing channels primarily in the United States and the United Kingdom. The company?s Affiliate Marketing segment provides technology platforms, advertising network, and customer services, which enable advertisers to create their own commissioned online sales force comprising third-party Website publishers. This segment offers its services under the Commission Junction brand. Its Media segment provides digital marketing services and tailored programs under ValueClick Media brand name that enable marketers to create and increase awareness for their products and brands; attract visitors; and generate leads and sales through the Internet and mobile applications. The company?s Owned & Operated Websites segment offers its services through various Websites comprising Pricerunner and Smarter.com Websites, which enable consumers to research and comp are products from online and/or offline merchants; Couponmountain.com Website that enables consumers to locate coupons and deals related to products and services; and Investopedia.com Website, which provides information on various financial and investment topics, including a proprietary dictionary of financial terms. This segment also operates vertical content Websites that offer consumers information and reference material in various topics in healthcare, finance, travel, home and garden, education, and business services. Its Technology segment operates as an application service provider and offers technology infrastructure tools and consultative services that enable marketers to implement and manage their online display advertising, search engine marketing, and email campaigns. The company serves direct marketers, advertisers, advertising agencies, and traffic distribution partners. ValueClick, Inc. was founded in 1998 and is headquartered in Westlake Village, California.< /p> Advisors' Opinion:
- [By Brian Pacampara]
What: Shares of digital marketing company ValueClick (NASDAQ: VCLK ) plummeted 17% today after its quarterly results and outlook disappointed Wall Street.
- [By Rich Smith]
ValueClick got toggled off
Google's�mini-rival in the market for online ads, ValueClick (NASDAQ: VCLK ) , beat earnings by a couple of cents in yesterday's earnings report. Unfortunately, this good news isn't translating into good grades on Wall Street, as a whole series of analysts cut their ratings on the stock to various flavors of "hold." Stephens and Cantor Fitzgerald, Craig-Hallum and Raymond James -- one and all, the analysts are downgrading ValueClick today -- but why?
Hot Net Payout Yield Companies To Own For 2014: Territorial Bancorp Inc.(TBNK)
Territorial Bancorp Inc. operates as the bank holding company for Territorial Savings Bank, a federally-chartered savings bank that provides a range of financial services to individuals, families, and businesses in Hawaii. It involves in accepting deposits from the general public and investing those deposits together with funds generated from operations and borrowings in loans and investment securities. The company?s deposit products include passbook and statement savings accounts, certificates of deposits, money market accounts, commercial and regular checking accounts, and NOW accounts. Its loan products include one-to-four-family residential mortgage loans; home equity loans and lines of credit; construction, commercial, and other non-residential real estate loans; consumer loans; and multi-family mortgage loans. The company, through its subsidiary, Territorial Financial Services, Inc., also engages in insurance agency activities. In addition, it provides various non-d eposit investments, including annuities and mutual funds through a third-party broker-dealer. As of December 31, 2010, the company operated 26 full-service branch offices in Hawaii. The company was founded in 1921 and is headquartered in Honolulu, Hawaii.
Advisors' Opinion:- [By Lisa Levin]
Territorial Bancorp (NASDAQ: TBNK) shares touched a new 52-week low of $21.31. Territorial Bancorp shares have dropped 9.43% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.
Hot Net Payout Yield Companies To Own For 2014: China Jo-Jo Drugstores Inc.(CJJD)
China Jo-Jo Drugstores, Inc. owns and operates a retail pharmacy chain in the People?s Republic of China. Its stores sell various medicinal products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicine products, personal care products, family care products, and medical devices, as well as convenience products including consumable, seasonal, and promotional items. The company also has licensed doctors, who provide consultation, examination, and treatment of common ailments. In addition, its stores include medical clinics that offer urgent care, traditional Chinese medicines, and minor outpatient surgical treatments. The company operates a chain of approximately 55 drugstores under the Jiuzhou Grand Pharmacy Quannuo Grand Pharmacy, and Lydia Grand Pharmacy brand names. The company is headquartered in Hangzhou, the People?s Republic of China.
Advisors' Opinion:- [By Bryan Murphy]
Although the market seems to be losing traction, and even losing ground now, the same can't be said of every single stock. A handful of stocks like China Jo-Jo Drugstores Inc. (NASDAQ:CJJD), Vuzix Corp. (OTCBB:VUZI), and Adamis Pharmaceuticals Corp. (NASDAQ:ADMP) are forging ahead, doling out gains against the grain. Not that moving higher while other names are moving lower is a sure sign that ADMP, VUZI, and CJJD will remain in their uptrends indefinitely, but it sure doesn't hurt their odds. Here's a closer look at each one and why you'd want to add them to your watchlist.
- [By Roberto Pedone]
Another under-$10 drug retailer that's starting to move within range of triggering a big breakout trade is China Jo-Jo Drugstores (CJJD), which operates as a retailer and distributor of pharmaceutical and other health care products in the People's Republic of China. This stock has been on fire for the last three months, with shares ripping higher by 46%.
If you take a look at the chart for China Jo-Jo Drugstores you'll notice that this stock has been uptrending strong over the last month and change, with shares moving higher from its low of 65 cents per share to its recent high of $1.18 a share. During that uptrend, shares of CJJD have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of CJJD within range of triggering a big breakout trade above some near-term and past overhead resistance levels.
Market players should now look for long-biased trades in CJJD if it manages to break out above some near-term overhead resistance at $1.18 a share and then once it clears some past overhead resistance levels at $1.21 to $1.32 a share high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 99,122 shares. If that breakout hits soon, then CJJD will set up to re-test or possibly take out its next major overhead resistance levels at $1.70 to its 52-week high at $1.99 a share.
Traders can look to buy CJJD off weakness to anticipate that breakout and simply use a stop that sits just below its 50-day moving average of 98 cents per share. One can also buy CJJD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Hot Net Payout Yield Companies To Own For 2014: ICF International Inc. (ICFI)
ICF International Inc. provides management, technology, and policy professional services to government, commercial, and international clients. It primarily offers advisory services, which include needs and market assessments, policy analysis, strategy and concept development, organizational assessment and strategy, enterprise architecture, and program design; and implementation services to manage technological, organizational, and management solutions for clients, including information technology solutions, project and program management, project delivery, strategic communications, and training. The company also provides evaluation and improvement services consisting of program evaluations, continuous improvement initiatives, performance management, benchmarking, and return-on-investment analyses. It serves energy, environment, and transportation; health, education, and social programs; and homeland security and defense. The company was formerly known as ICF Consulting Gro up Holdings, LLC and changed its name to ICF International, Inc. in 2006. The company was founded in 1969 and is headquartered in Fairfax, Virginia.
Advisors' Opinion:- [By John Leonard]
Key takeaways
ICF International (ICFI) trades at an attractive multiple due to concerns that lower government spending (~three quarters of its business) will negatively affect results.However recent contract wins and an expected strong 2H mitigate these concerns.Moreover, a successful acquisition strategy reduced its dependence on government spending and resulted in significant EBITDA growth, high free cash flow and an almost 50% debt reduction.Company overview
Hot Net Payout Yield Companies To Own For 2014: Furiex Pharmaceuticals Inc (FURX)
Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company�� product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.
Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). Alogliptin is a DPP-4 inhibitor that slows the inactivation of incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).
Fluoroquinolone drug candidate is a Phase II-ready novel fluoroquinolone antibiotic that is being developed by the Company for the treatment of complicated skin and skin structure infections, such as abscesses that occur deep in the skin layers and respiratory infections. This antibiotic has a spectrum of activity and is able to treat methicillin-resistant staphylococcus aureus (MRSA) infections. The Company is developing both oral and intravenous (IV) formulations. The Company is developing Mu Delta for treatment of diarrheal predominant irritable bowel syndrome (d-IBS). The Company is conducting a Phase II study on an oral formulation of Mu Delta.
The Company is developing PPD 10558 for the treatment of dyslipidemia. PPD 10558 has shown muscle safety in preclinical studies by minimizing the delivery of the drug to the muscle. The Company has filed an inve! stigational new drug (IND) application with the United States Food and Drug Association and completed five clinical studies.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top Headline
Forest Laboratories (NYSE: FRX) announced its plans to buy Furiex Pharmaceuticals (NASDAQ: FURX) for up to $1.46 billion. Forest will pay around $95 per share, or around $1.1 billion in cash. Forest Labs will also pay up to $30 per share, or around $360 million in a contingent value right. The deal is projected to close in the second or third quarter of 2014. - [By John Udovich]
Yesterday, small cap drug development collaboration company Furiex Pharmaceuticals Inc (NASDAQ: FURX) surged 129.91% after announcing that its experimental drug had alleviated diarrhea and abdominal pain caused by irritable bowel syndrome in two studies, meaning its worth taking a closer look at the stock because that�� a condition that effects millions of people (with no other effective drug to treat it) plus take a look at the�performance of biotech benchmarks iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By CRWE]
Furiex Pharmaceuticals, Inc. (NASDAQ:FURX) reported dosing of the first patient in its Phase III randomized, double-blind, placebo-controlled studies evaluating efficacy, safety and tolerability of MuDelta (JNJ-27018966) in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D).
- [By Lisa Levin]
Furiex Pharmaceuticals (NASDAQ: FURX) shares moved up 28.41% to $102.92. The volume of Furiex Pharmaceuticals shares traded was 2285% higher than normal. Forest Labs (NYSE: FRX) announced its plans to buy Furiex Pharma for up to $1.46 billion.
Hot Net Payout Yield Companies To Own For 2014: Conmed Corp (CNMD)
CONMED Corporation (CONMED), incorporated on February 10, 1970, is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care.
Arthroscopy
The Company offers a range of devices and products for uses in arthroscopic surgery. The Company's arthroscopy products include powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants as well as related disposable products and fluid management systems. The Company also offers a line of video Endoscopy products suitable for uses in multi-specialty clinical environments beyond orthopedic arthroscopy, including laparoscopy, ear, nose and throat (ENT), gynecology and urology, as well as integrated operating room systems and equipment.
Powered Surgical Instruments
Electric, battery or pneumatic powered surgical instruments are used to perform orthopedic, arthroscopic and other surgical procedures where cutting, drilling or reaming of bone is required. Each power system consists of one or more handpieces and related accessories as well as disposable and limited reusable items (e.g., burs, saw blades, drills and reamers). Powered instruments are categorized as either small bone, large bone or specialty powered instruments. Specialty powered instruments are utilized in procedures such as spinal surgery, neurosurgery, ENT, oral/maxillofacial surgery, and cardiothoracic surgery.
The Company's line of powered instruments is sold principally under the Hall Surgical brand name, for use in large and small bone orthopedic, arthroscopic, oral/maxillofaci! al, podiatric, plastic, ENT, neurological, spinal and cardiothoracic surgeries. Large bone, neurosurgical, spinal and cardiothoracic powered instruments are sold primarily to hospitals while small bone arthroscopic, otolaryngological and oral/maxillofacial powered instruments are sold to hospitals, outpatient facilities and physicians offices.
The Company's powered instruments product line includes the MPower battery system. This orthopedic power system is specifically designed to meet the requirements of orthopedic applications. The MPower battery system allows a facility to purchase a single power system to perform total joint arthroplasty, trauma, arthroscopy, and small bone procedures. The system also provides a multitude of battery technologies to meet the varying needs of hospitals worldwide.
Electrosurgery
The use of electrosurgical units and associated surgical tools is commonplace in the hospital surgical suite, surgery centers, clinics and physician offices. Electrosurgery is routinely used to cut and coagulate tissue and small vessels in open and laparoscopic procedures using energy produced through radio frequency (RF) technology. Electrosurgery can be used in almost all surgical procedures including specialties, such as general, gynecology, orthopedics, cardiology, thoracics, urology, neurology, and dermatology. The Company�� portfolio consist of energy-based products is the Argon Beam Coagulation (ABC) technology. ABC technology combines the use of argon gas and electrosurgical energy to allow the surgeon to produce a surface coagulation which results in less tissue damage.
Patient Care
The Company's patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs. The Company also offers a line of suction instruments and tubing for use in the! operatin! g room, as well as a line of intravenous (IV) products for use in the critical care areas of the hospital.
Endosurgery
Endosurgery (also referred to as minimally invasive surgery or laparoscopic surgery) is surgery performed without a incision. The Company's Endosurgical products include the Reflex and PermaClip clip appliers for vessel and duct ligation, Universal S/I (suction/irrigation) and Universal Plus laparoscopic instruments and specialized suction/irrigation electrosurgical instrument systems for use in laparoscopic surgery. The Company also offers cutting and dilating trocars, suction/irrigation accessories, laparoscopic scissors, dissectors and graspers, active electrodes, insufflation needles and linear cutters and staplers for use in laparoscopic surgery. The Company's disposable skin staplers are used to close large skin incisions with surgical staples, thus eliminating the time consuming suturing process. CONMED Endosurgery also offers a uterine manipulator called VCARE for use in increasing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures.
Endoscopic Technologies
The Company offers a line of minimally invasive diagnostic and therapeutic products used in conjunction with procedures, which requires flexible endoscopy. The Company's principal customers include gastrointestinal (GI) endoscopists, pulmonologists, and nurses who perform both diagnostic and therapeutic endoscopic procedures in hospitals and outpatient clinics.
The Company's primary focus is to identify, develop, acquire, manufacture and market differentiated medical devices, which improve outcomes in the diagnosis and treatment of gastrointestinal and pulmonary disorders. The Company's diagnostic and therapeutic product offerings for GI and pulmonology include mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and ! polypecto! my.
The Company competes with Smith & Nephew, plc, Arthrex, Inc., Stryker Corporation, ArthroCare Corporation, Johnson & Johnson: DePuy Mitek, Inc., Biomet, Inc., Medtronic, Inc. Midas Rex and Xomed, Synvasive Technology, Inc., Synthes, Inc., MicroAire Surgical Instruments, LLC, Zimmer Holdings, Inc., Covidien Ltd.; Valleylab, Medline Industries, Inc., ERBE Elektromedizin GmbH, Megadyne, Kendall, 3M Company, Ethicon Endo-Surgery, Inc, U.S.Surgical, Boston Scientific Corporation, Wilson-Cook Medical, Inc, Olympus America, Inc. and STERIS Corporation.
Advisors' Opinion:- [By Seth Jayson]
Margins matter. The more CONMED (Nasdaq: CNMD ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong CONMED's competitive position could be.
Hot Net Payout Yield Companies To Own For 2014: Black Hills Corporation (BKH)
Black Hills Corporation, together with its subsidiaries, operates as a diversified energy company in the United States. The company’s Electric Utilities segment generates, transmits, and distributes electricity to approximately 202,000 electric customers in South Dakota, Wyoming, Colorado, and Montana; and distributes natural gas to approximately 35,000 gas utility customers in Cheyenne, Wyoming. It owns 859 Megawatts of generation capacity and 8,530 miles of electric transmission and distribution lines. The company’s Gas Utilities segment distributes natural gas to approximately 532,000 natural gas utility customers in Colorado, Nebraska, Iowa, and Kansas. It owns 624 miles of intrastate gas transmission pipelines and 19,979 miles of gas distribution mains and service lines. The company’s Oil and Gas segment is involved in the acquisition, exploration, development, and production of crude oil and natural gas primarily in the Rocky Mountain region. This s egment’s principal assets include the operating interests in the properties in the San Juan basin, the Powder River basin, and the Piceance basin; and non-operated interests in wells located in the Williston, Wind River, Bear Paw Uplift, Arkoma, Anadarko, and Sacramento basins. As of December 31, 2012, it had total reserves of approximately 81 billion cubic feet equivalent of natural gas and crude oil. The company’s Power Generation segment produces electric power and sells the electric capacity and energy primarily to other utilities under long-term contracts. Its Coal Mining segment produces coal at its coal mine located near Gillette, Wyoming. The company also provides appliance repair services to approximately 62,000 residential customers; and constructs gas infrastructure facilities for gas transportation customers. Black Hills Corporation was founded in 1941 and is headquartered in Rapid City, South Dakota.
Advisors' Opinion:- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Black Hills Corporation (NYSE: BKH), CME Group Inc. (NASDAQ: CME), Leapfrog Enterprises (NYSE: LF), Hill International, Inc. (NYSE: HIL) Economic Releases Expected: eurozone manufacturing PMI, British construction PMI, US factory orders, Chinese services PMI, Indian services PMITuesday
- [By Marc Bastow]
Diversified energy company Black Hills (BKH) raised its quarterly dividend 2.6% to 39 cents per share, payable on Mar. 1 to shareholders of record as of Feb. 14. This is the 44th consecutive annual dividend increase, proving why utilities make such consistent dividend stocks.
BKH Dividend Yield: 2.84%
No comments:
Post a Comment